-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Downgrades NeuroSense Therapeutics to Neutral

Benzinga·11/02/2026 17:32:20
Listen to the news
HC Wainwright & Co. analyst Lander Egaña Gorroño downgrades NeuroSense Therapeutics (NASDAQ:NRSN) from Buy to Neutral.